IL6 and COVID-19: A retrospective study in patients admitted to the intensive care unit (ICU) with confirmed COVID-19 showed highly elevated levels of IL-6 and delayed cytotoxic immune responses, which are characteristics of severe COVID-19-induced ARDS [58].